These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 8192157
21. [Progress on the study of related genes in patients with blast crisis of chronic myelocytic leukemia]. Xiong H, Chen X. Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):49-51. PubMed ID: 11498844 [No Abstract] [Full Text] [Related]
22. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia. Ma CC, Chai Y, Chen HL, Wang X, Gao Y, Hu WL, Xiang X. J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154 [Abstract] [Full Text] [Related]
23. Fluorescent in situ hybridization diagnosis of extramedullary nodal blast crisis. Jin GN, Zou P, Chen WX, Ding ZY, Zhou H. Diagn Cytopathol; 2013 Mar; 41(3):253-6. PubMed ID: 23417967 [Abstract] [Full Text] [Related]
24. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement]. Fujiwara H, Takahashi N, Tada J, Higuchi T, Harada H, Mori H, Niikura H, Omine M, Fujita K. Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272 [Abstract] [Full Text] [Related]
29. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients. Nakajima H, Zhao R, Lund TC, Ward J, Dolan M, Hirsch B, Miller JS. J Immunol; 2002 Jan 15; 168(2):643-50. PubMed ID: 11777957 [Abstract] [Full Text] [Related]
30. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis. Kolenova A, Maloney KW, Hunger SP. J Pediatr Hematol Oncol; 2016 Aug 15; 38(6):e193-5. PubMed ID: 27164534 [Abstract] [Full Text] [Related]
33. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia. Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM. Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536 [Abstract] [Full Text] [Related]
34. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis. Stagno F, Stella S, Berretta S, Massimino M, Antolino A, Giustolisi R, Messina A, Di Raimondo F, Vigneri P. Leuk Res; 2008 Apr 01; 32(4):673-4. PubMed ID: 17889935 [No Abstract] [Full Text] [Related]
35. Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2). Bustamante D, Chan KR, Czuchlewski DR, Saadi AA. Int J Hematol; 2012 Mar 01; 95(3):324-6. PubMed ID: 22370710 [No Abstract] [Full Text] [Related]
36. Near haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe. Gancberg D, Dargent JL, Verhest A, Kentos A, Feremans W, Lohrisch C, Kornreich A. Cancer Genet Cytogenet; 2001 Jul 15; 128(2):172-4. PubMed ID: 11478300 [No Abstract] [Full Text] [Related]
37. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration. Campbell LJ, Patsouris C, Rayeroux KC, Somana K, Januszewicz EH, Szer J. Cancer Genet Cytogenet; 2002 Nov 15; 139(1):30-3. PubMed ID: 12547154 [Abstract] [Full Text] [Related]